Table 2 |
||||||||
| Immunological parameters: pre and post treatment immune marker comparison between the two groups of depressed subjects | ||||||||
| Omega-3 group (n=22) | Placebo group (n=24) | Tests | ||||||
| Pre-treatment | Post-treatment | Pre-treatment | Post-treatment | |||||
| Mean (Std.dev.) | Mean (Std.dev.) | Mean (Std.dev.) | Mean (Std.dev.) | 1 | 2 | 3 | 4 | |
| CD2 | 84.2 (12.2) | 82.9 (12.9) | 88.4 (5.5) | 87.9 (8.0) | ||||
| CD19 | 9.0 (10.9) | 10.6 (10.2) | 6.2 (4.5) | 10.9 (18.3) | ||||
| CD3 | 66.1 (12.8) | 66.5 (12.9) | 69.8 (8.8) | 70.6 (9.6) | ||||
| CD4 | 41.4 (14.3) | 39.1 (16.3) | 44.4 (7.9) | 41.4 (11.9) | ||||
| CD8 | 31.9 (13.4) | 29.1 (13.9) | 29.5 (8.1) | 30.9 (9.6) | ||||
| CD16 | 13.0 (9.3) | 16.5 (10.8) | 12.4 (6.2) | 15.0 (8.6) | * | |||
| CD4/CD8 | 1.58 (0.96) | 1.68 (1.17) | 1.66 (0.85) | 1.45 (0.64) | ||||
| IL-5 | 1.69 (0.60) | 1.89 (1.28) | 4.36 (8.22) | 3.23 (5.90) | ||||
| IL-15 | 5.86 (3.88) | 8.11 (6.14) | 5.88 (3.32) | 5.99 (5.41) | ||||
1 Student’s paired t-test or Wilcoxon signed-rank test to compare post-treatment to baseline values within n-3 group.
2 Student’s paired t-test or Wilcoxon signed-rank test to compare post-treatment to baseline values within placebo group.
3 Unpaired t-test or Wilcoxon rank sum test to compare baseline values between n-3 and placebo group.
4 Unpaired t-test or Wilcoxon rank sum test to compare changes from baseline values between n-3 and placebo group.
* p<0.05.
Rizzo et al. Nutrition Journal 2012 11:82 doi:10.1186/1475-2891-11-82
